Follow
Rafik Karaman
Rafik Karaman
Distinguished Professor of Pharmaceutical Sciences, Al-Quds University
Verified email at pharm.alquds.edu - Homepage
Title
Cited by
Cited by
Year
Comprehensive Review on Alzheimer's Disease: Causes and Treatment
Z Breijyeh, R Karaman
Molecules 25, 5789, 2020
15602020
Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It
Z Breijyeh, B Jubeh, R Karaman
Molecules 25 (1340), 1-23, 2020
11062020
Resistance of gram-positive bacteria to current antibacterial agents and overcoming approaches
B Jubeh, Z Breijyeh, R Karaman
Molecules 25 (12), 2888, 2020
2752020
The Biological Activity of Natural Alkaloids against Herbivores, Cancerous Cells and Pathogens
A Thawabteh, S Jumaa, M Bader, D Karaman, L Scrano, SA Bufo, ...
Toxins 11 (656), 1-28, 2019
2332019
Dopamine and levodopa prodrugs for the treatment of Parkinson’s disease
F Haddad, M Sawalha, Y Khawaja, A Najjar, R Karaman
Molecules 23 (1), 40, 2017
1642017
Prodrugs Design Based on Inter‐and Intramolecular Chemical Processes
R Karaman
Chemical biology & drug design 82 (6), 643-668, 2013
1262013
Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach
A Dahan, M Khamis, R Agbaria, R Karaman
Expert opinion on drug delivery 9 (8), 1001-1013, 2012
992012
Computer-assisted design for paracetamol masking bitter taste prodrugs
H Hejaz, R Karaman, M Khamis
Journal of molecular modeling 18, 103-114, 2012
992012
Analysis of Menger’s ‘spatiotemporal hypothesis’
R Karaman
Tetrahedron Letters 49 (41), 5998-6002, 2008
902008
Acylphosphonic acids and methyl hydrogen acylphosphonates: physical and chemical properties and theoretical calculations
R Karaman, A Goldblum, E Breuer, H Leader
Journal of the Chemical Society, Perkin Transactions 1, 765-774, 1989
901989
Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses
Z Breijyeh, B Jubeh, SA Bufo, R Karaman, L Scrano
toxins 13 (2), 117, 2021
882021
Prodrugs for masking bitter taste of antibacterial drugs—a computational approach
R Karaman
Journal of molecular modeling 19, 2399-2412, 2013
832013
The prodrug approach in the era of drug design
A Najjar, R Karaman
Expert opinion on drug delivery 16 (1), 1-5, 2019
822019
Comparing Class A GPCRs to bitter taste receptors: Structural motifs, ligand interactions and agonist-to-antagonist ratios
A Di Pizio, A Levit, M Slutzki, M Behrens, R Karaman, MY Niv
Methods in cell biology 132, 401-427, 2016
822016
Antibacterial Prodrugs to Overcome Bacterial Resistance
B Jubeh, Z Breijyeh, R Karaman
Molecules 25 (1543), 1-16, 2020
732020
The future of prodrugs–design by quantum mechanics methods
R Karaman, B Fattash, A Qtait
Expert opinion on drug delivery 10 (5), 713-729, 2013
712013
Prodrugs of acyclovir–a computational approach
R Karaman, KK Dajani, A Qtait, M Khamis
Chemical biology & drug design 79 (5), 819-834, 2012
712012
Prodrugs of aza nucleosides based on proton transfer reaction
R Karaman
Journal of computer-aided molecular design 24, 961-970, 2010
712010
The efficiency of proton transfer in Kirby’s enzyme model, a computational approach
R Karaman
Tetrahedron Letters 51 (16), 2130-2135, 2010
692010
Reevaluation of Bruice’s proximity orientation
R Karaman
Tetrahedron Letters 50 (4), 452-456, 2009
692009
The system can't perform the operation now. Try again later.
Articles 1–20